BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26853890)

  • 21. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
    Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
    Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
    Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.
    He N; Huang P; Ling H; Langley J; Liu C; Ding B; Huang J; Xu H; Zhang Y; Zhang Z; Hu X; Chen S; Yan F
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27192177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
    Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
    J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
    Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
    J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histogram Analysis of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson's Disease.
    Zhang Y; Yang M; Wang F; Chen Y; Liu R; Zhang Z; Jiang Z
    Acad Radiol; 2022 Mar; 29 Suppl 3():S71-S79. PubMed ID: 33189552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproducibility of R
    Santin MD; Didier M; Valabrègue R; Yahia Cherif L; García-Lorenzo D; Loureiro de Sousa P; Bardinet E; Lehéricy S
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26913373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease.
    Takahashi H; Watanabe Y; Tanaka H; Mihara M; Mochizuki H; Takahashi K; Yamamoto K; Liu T; Wang Y; Tomiyama N
    Eur J Radiol; 2018 Dec; 109():48-56. PubMed ID: 30527311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
    Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
    Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease.
    Xiao B; He N; Wang Q; Cheng Z; Jiao Y; Haacke EM; Yan F; Shi F
    Neuroimage Clin; 2019; 24():102070. PubMed ID: 31734535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
    Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
    ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
    [No Abstract]   [Full Text] [Related]  

  • 34. Combining quantitative susceptibility mapping to radiomics in diagnosing Parkinson's disease and assessing cognitive impairment.
    Kang JJ; Chen Y; Xu GD; Bao SL; Wang J; Ge M; Shen LH; Jia ZZ
    Eur Radiol; 2022 Oct; 32(10):6992-7003. PubMed ID: 35461376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron accumulation in the ventral tegmental area in Parkinson's disease.
    Zhang D; Yao J; Sun J; Wang J; Chen L; He H; Wu T
    Front Aging Neurosci; 2023; 15():1187684. PubMed ID: 37448687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
    Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
    Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
    He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
    Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
    Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
    Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different iron deposition patterns in early- and middle-late-onset Parkinson's disease.
    Xuan M; Guan X; Gu Q; Shen Z; Yu X; Qiu T; Luo X; Song R; Jiaerken Y; Xu X; Huang P; Luo W; Zhang M
    Parkinsonism Relat Disord; 2017 Nov; 44():23-27. PubMed ID: 28838722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.